www.alliancepharma.co.uk
Alliance Pharma plc is a United Kingdom-based pharmaceutical company. The Company is engaged in the development, marketing and distribution of pharmaceutical products. Its brands include Nu-Seals, Forceval, Hydromol, Deltacortril, Symmetrel, Syntocinon, Naseptin, Syntometrine, Synacthen and Slow-K.
Alliance Pharma profits forecast to meet expectations
Alliance Pharma (LON:APH) said pre-tax profits will be in line with market expectations with annual revenues predicted to be around £46 million for the year just ended.
In a pre-close trading update the speciality pharmaceutical group said its Deltacortril steroid pill continued to be affected by increased competition. Total sales for the 12 months to December 31 were £4.7 million, with £1.1 million coming in the second half.
However it added that sales of its Hydromol cream and ImmuCyst for bladder cancer “continued to grow well”.
Revenues from Nu-Seals, a coated aspirin tablet used as an anti-clotting agent sold mainly in the Republic of Ireland, were up 14 per cent to £5.4 million.
“We are implementing a number of efficiency measures and other cost savings and believe that these steps, together with the impact of the three acquisitions completed in 2011, should largely compensate for the impact of the further reduction in sales of Deltacortril and the risk to Nu-Seals,” the company said.


















